These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26309431)

  • 41. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
    Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
    BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Metformin, Acarbose and Their Combination on the Serum Visfatin Level in Nicotinamide/Streptozocin-Induced Type 2 Diabetic Rats.
    Salemi Z; Rafie E; Goodarzi MT; Ghaffari MA
    Iran Red Crescent Med J; 2016 Mar; 18(3):e23814. PubMed ID: 27247792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the combined use of insulin resistance indices, including adipokines, more reliable in metabolic syndrome?
    Kural B; Değer O; Erem C; Balaban Yücesan F; Aliyazicioğlu R; Barlak Y
    Turk J Med Sci; 2014; 44(6):1021-8. PubMed ID: 25552156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum ghrelin levels in patients with Behcet's disease.
    Erden I; Uçak H; Demir B; Cicek D; Dertlioğlu SB; Aydin S; Ozturk S
    Postepy Dermatol Alergol; 2016 Dec; 33(6):450-456. PubMed ID: 28035223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome.
    Pereira GB; Tibana RA; Navalta J; Sousa NM; Córdova C; Souza VC; Nóbrega OT; Prestes J; Perez SE
    Clin Physiol Funct Imaging; 2013 Mar; 33(2):122-30. PubMed ID: 23383690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
    Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
    PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum Caveolin-1 Level is Inversely Associated with Serum Vaspin, Visfatin, and HbA1c in Newly Diagnosed Men with Type-2 Diabetes.
    Ali HH; Al-Rawi K; Khalaf Y; Alaaraji S; Aldahham B; Awad M; Al-Ani O; Al-Ani F; Ali AT
    Rep Biochem Mol Biol; 2022 Jul; 11(2):299-309. PubMed ID: 36164629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small dense LDL cholesterol measured by homogeneous assay in Japanese healthy controls, metabolic syndrome and diabetes patients with or without a fatty liver.
    Kikkawa K; Nakajima K; Shimomura Y; Tokita Y; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Jan; 438():70-9. PubMed ID: 25050800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis.
    Kadoglou NP; Fotiadis G; Lambadiari V; Maratou E; Dimitriadis G; Liapis CD
    Peptides; 2014 Jul; 57():12-6. PubMed ID: 24768795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose metabolism alterations in patients with bipolar disorder.
    Rosso G; Cattaneo A; Zanardini R; Gennarelli M; Maina G; Bocchio-Chiavetto L
    J Affect Disord; 2015 Sep; 184():293-8. PubMed ID: 26120808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum visfatin increases with progressive beta-cell deterioration.
    López-Bermejo A; Chico-Julià B; Fernàndez-Balsells M; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
    Diabetes; 2006 Oct; 55(10):2871-5. PubMed ID: 17003355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes.
    AbuZayed R; Bulatova N; Kasabri V; Suyagh M; Halaseh L; AlAlawi S
    Horm Mol Biol Clin Investig; 2019 Jan; 37(3):. PubMed ID: 30667367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma visfatin and ghrelin response to prolonged sculling in competitive male rowers.
    Jürimäe J; Rämson R; Mäestu J; Purge P; Jürimäe T; Arciero PJ; von Duvillard SP
    Med Sci Sports Exerc; 2009 Jan; 41(1):137-43. PubMed ID: 19092696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus.
    Boyuk B; Degirmencioglu S; Atalay H; Guzel S; Acar A; Celebi A; Ekizoglu I; Simsek C
    J Diabetes Res; 2014; 2014():978143. PubMed ID: 25587547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome.
    Catak Z; Aydin S; Sahin I; Kuloglu T; Aksoy A; Dagli AF
    Neuropeptides; 2014 Jun; 48(3):167-77. PubMed ID: 24786976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoprotegerin is not a determinant of metabolic syndrome in sub-Saharan Africans after age adjustment.
    Ayina Ayina CN; Boudou P; Fidaa I; Balti EV; Sobngwi E; Etoundi Ngoa LS; Gautier JF
    Ann Endocrinol (Paris); 2014 Jul; 75(3):165-70. PubMed ID: 25063075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver.
    Shaker O; El-Shehaby A; Zakaria A; Mostafa N; Talaat S; Katsiki N; Mikhailidis DP
    Clin Biochem; 2011 Dec; 44(17-18):1457-63. PubMed ID: 21939650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.